Related Experiment Video
Updated: Oct 18, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Attenuation of PITPNM1 Signaling Cascade Can Inhibit Breast Cancer Progression
Zihao Liu1,2, Yu Shi1,2, Qun Lin1,2
1Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Abstract:
Phosphatidylinositol transfer protein membrane-associated 1 (PITPNM1) contains a highly conserved phosphatidylinositol transfer domain which is involved in phosphoinositide trafficking and signaling transduction under physiological conditions. However, the functional role of PITPNM1 in cancer progression remains unknown. Here, by integrating datasets of The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer (METABRIC), we found that the expression of PITPNM1 is much higher in breast cancer tissues than in normal breast tissues, and a high expression of PITPNM1 predicts a poor prognosis for breast cancer patients. Through gene set variation analysis (GSEA) and gene ontology (GO) analysis, we found PITPNM1 is mainly associated with carcinogenesis and cell-to-cell signaling ontology. Silencing of PITPNM1, in vitro, significantly abrogates proliferation and colony formation of breast cancer cells. Collectively, PITPNM1 is an important prognostic indicator and a potential therapeutic target for breast cancer.
Insights
Phosphatidylinositol transfer protein membrane-associated 1 (PITPNM1) is highly expressed in breast cancer, indicating a poor prognosis. Silencing PITPNM1 reduces cancer cell proliferation, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Phosphatidylinositol transfer protein membrane-associated 1 (PITPNM1) has a conserved domain involved in phosphoinositide trafficking and signaling.
- The role of PITPNM1 in cancer progression, particularly breast cancer, is currently unknown.
Purpose of the Study:
- To investigate the functional role of PITPNM1 in breast cancer progression.
- To determine if PITPNM1 expression correlates with patient prognosis and can serve as a therapeutic target.
Main Methods:
- Integrated analysis of The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer (METABRIC) datasets.
- Gene Set Variation Analysis (GSEA) and Gene Ontology (GO) analysis.
- In vitro experiments involving silencing of PITPNM1 in breast cancer cells.
Main Results:
- PITPNM1 expression is significantly elevated in breast cancer tissues compared to normal tissues.
- High PITPNM1 expression is associated with a poor prognosis in breast cancer patients.
- Silencing PITPNM1 inhibited breast cancer cell proliferation and colony formation in vitro.
- GSEA and GO analyses linked PITPNM1 to carcinogenesis and cell-to-cell signaling pathways.
Conclusions:
- PITPNM1 is upregulated in breast cancer and serves as a significant prognostic indicator.
- PITPNM1 plays a role in promoting breast cancer cell proliferation and colony formation.
- PITPNM1 represents a potential therapeutic target for breast cancer treatment.
More Related Videos
11:06Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Published on: May 20, 2015
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway